The spine biologics market is growing due to increasing spinal fusion procedures. Current trends include rising use of bone grafts and cell-based therapies.
The global orthobiologics market is expected to reach USD 9.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033 (IMARC Group).
Key market growth factors include rising demand for orthobiologics by orthopedic surgeons, to promote faster healing of injuries, and increasing osteoarthritis prevalence.
BiologicsCorp, based in Indianapolis, specializes in recombinant protein expression and purification. They provide cytokines, chemokines, growth factors, and viral antigens.
The "Top Selling Biologics Market" report features an extensive study of the current market landscape and future potential of the top selling biologics available for the treatment of a variety of disease indications.
Bio-Processing Alliance Inc. offers biologics development and cGMP manufacturing assistance to innovator and service companies. Services include technology transfer.
Comprehensive Biologics and Dr. Buzz advance healthcare through regenerative medicine. BiologicalMatrix-50, BiologicalMatrix Pro, and BiologicalAmnio are minimally manipulated allografts.
ROS Aesthetics offers biologics treatments for skin, using natural and advanced solutions for rejuvenation, anti-aging, and healing, resulting in youthful skin.
The global biologics contract manufacturing market is estimated to reach over $19 billion and is expected to grow at a compound annual growth rate (CAGR) of ~9% during the forecast period.
BioMarketplace offers life and biotech industries innovative ways to obtain blood, biologics, lab and professional services, and technological products.
Orthopedic devices are used for restoring skeletal structure and joint movements in various fractures, abnormal growth of bones, soft tissue damage, trauma or other deformities.